Saturn V Capital Management’s Enliven Therapeutics ELVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-152,178	Closed	-$3.56M	–	27
2024 Q2	$3.56M	Buy	+152,178	New	+$3.56M	1.34%	22